Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
ISD Protocol for nuclear export signal characterization of cGAS in mammalian cells. 2021 STAR Protoc. Huang Y. et al. DOI: 10.1016/j.xpro.2021.100649
pVITRO2-MCS Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts ... 2021 Hepatol Commun. Chen K. et al. DOI: 10.1002/hep4.1701
5'ppp-dsRNA Control Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD... 2021 J Biol Chem. Paz Rijo M. et al. DOI: 10.1016/j.jbc.2021.100886
5'ppp-dsRNA Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD... 2021 J Biol Chem. Paz Rijo M. et al. DOI: 10.1016/j.jbc.2021.100886
Leptomycin B Quantitative Nucleocytoplasmic Transport Assays in Cellular Models of Neurode... 2020 Bio Protoc. Vanneste J. et al. DOI: 10.21769/BioProtoc.3659
Leptomycin B Intron-containing RNA from the HIV-1 provirus activates type I interferon and... 2018 Nat Commun. McCauley S.M. et al. DOI: 10.1038/s41467-018-07753-2
Leptomycin B Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmen... 2020 Nat Cell Biol. Vietri M. et al. DOI: 10.1038/s41556-020-0537-5
Leptomycin B C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocy... 2019 Sci Rep. Vanneste J. et al. DOI: 10.1038/s41598-019-52035-6
Puromycin LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in ... 2021 J Hematol Oncol. Qian X. et al. DOI: 10.1186/s13045-021-01123-0
Human ACE2 expressing A549 Cells In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. 2021 Sci Rep. Zhou Y. et al. DOI: 10.1038/s41598-021-93361-y
Puromycin In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. 2021 Sci Rep. Zhou Y. et al. DOI: 10.1038/s41598-021-93361-y
HEK-Blue™ hTLR2 Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
HEK-Blue™ Selection Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
ORN06/LyoVec™ Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
R848 (Resiquimod) Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
Zeocin™ Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
HEK-Blue™ hTLR4 Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
HEK-Blue™ Null1 Cells Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
Blasticidin Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4
QUANTI-Blue™ Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonists. 2021 Nat Commun. Yang Y. et al. DOI: 10.1038/s41467-021-24536-4

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty